Ieq Capital LLC Invests $907,000 in Ardent Health, Inc. $ARDT

Ieq Capital LLC acquired a new stake in shares of Ardent Health, Inc. (NYSE:ARDT) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 92,191 shares of the company’s stock, valued at approximately $907,000.

A number of other hedge funds also recently made changes to their positions in ARDT. Caitong International Asset Management Co. Ltd grew its position in Ardent Health by 1,177.7% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after acquiring an additional 2,638 shares in the last quarter. Allworth Financial LP purchased a new stake in Ardent Health during the second quarter valued at about $28,000. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in Ardent Health during the third quarter worth about $61,000. Monetary Solutions Ltd bought a new stake in Ardent Health during the fourth quarter worth about $79,000. Finally, New York State Common Retirement Fund boosted its holdings in shares of Ardent Health by 121.4% in the 2nd quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after purchasing an additional 3,400 shares in the last quarter.

Ardent Health Stock Down 2.4%

Shares of NYSE:ARDT opened at $10.96 on Friday. The stock has a market capitalization of $1.55 billion, a P/E ratio of 19.94, a price-to-earnings-growth ratio of 3.15 and a beta of 0.70. The stock’s 50-day moving average price is $10.51 and its 200-day moving average price is $9.75. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. Ardent Health, Inc. has a 12-month low of $7.71 and a 12-month high of $15.48.

Ardent Health (NYSE:ARDT) last released its earnings results on Tuesday, August 4th. The company reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.06). The company had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.59 billion. Ardent Health had a net margin of 1.22% and a return on equity of 10.35%. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, equities analysts anticipate that Ardent Health, Inc. will post 0.97 earnings per share for the current year.

Insider Buying and Selling

In related news, CFO Alfred Lumsdaine acquired 10,000 shares of the stock in a transaction on Friday, June 5th. The stock was purchased at an average price of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the transaction, the chief financial officer owned 329,183 shares of the company’s stock, valued at $2,900,102.23. This trade represents a 3.13% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.90% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. The Goldman Sachs Group reiterated a “neutral” rating and set a $13.00 price objective on shares of Ardent Health in a research report on Thursday, August 6th. Wall Street Zen downgraded Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Guggenheim increased their price target on shares of Ardent Health from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Zacks Research downgraded shares of Ardent Health from a “hold” rating to a “strong sell” rating in a research note on Thursday, August 6th. Finally, Truist Financial boosted their price objective on shares of Ardent Health from $12.00 to $13.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. Seven research analysts have rated the stock with a Buy rating, four have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $13.05.

Ardent Health Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.